Is Colgate-Palmolive a buy or sell going into earnings? Read our full analysis here, it’s free. This quarter, analysts are expecting Colgate-Palmolive’s revenue to grow 1.9% year on year to $5 ...

Shares of Colgate-Palmolive Inc. reversed into the red premarket Friday, after the toothpaste and toothbrush giant beat third-quarter earnings expectations, but saw relative weakness in North ...

LG H&H Co. Ltd. 1.31% ₩5.39T LG H&H Co. Ltd. Pfd. Series 1 0.28% ₩5.39T ...

NBC Securities Inc. increased its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 49.3% during the third quarter, HoldingsChannel reports. The fund owned 5,463 shares of the ...

Claro Advisors LLC reduced its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 85.4% during the third quarter, according to the company in its most recent 13F filing with the SEC.

In a report released yesterday, Andrea Faria Teixeira from J.P. Morgan maintained a Buy rating on Colgate-Palmolive (CL – Research Report), with a price target of $109.00. Andrea Faria Teixeira ...

Learn more about ThePackHub's Innovation Zone here. Colgate-Palmolive has transitioned its Palmolive personal care range in Australia and New Zealand to bottles made from 100% recycled plastic. The ...

Colgate-Palmolive (CL – Research Report), the Consumer Defensive sector company, was revisited by a Wall Street analyst yesterday. Analyst Mark Astrachan from Stifel Nicolaus downgraded the ...

Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.86 per share a year ago.

Ratings for Colgate-Palmolive (NYSE:CL) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ...